+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
FEMALE
Healthy Volunteers
ID06858787

Assessing Continuous Glucose Monitoring to Diagnose Gestational Diabetes in Pregnant Women Receiving Prenatal Care at Mount Sinai Hospital

Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-08-13

150

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of a continuous glucose monitor CGM to diagnose gestational diabetes mellitus GDM in pregnant individuals. This pilot study includes women aged 18 to 50 receiving prenatal care at Mount Sinai Hospital. The goal is to assess how well the CGM works compared to standard glucose testing. Participants will wear a continuous glucose monitor device applied to their upper arm for 10 days. This device measures glucose levels in the fluid under the skin and sends the data to a mobile app. The study focuses on women with a single pregnancy between 24 and 32 weeks gestation who are receiving prenatal care at Mount Sinai Hospital. During the study, participants will have their blood glucose monitored continuously by the CGM, and standard glucose tolerance tests GTT at 1 and 3 hours will be done for comparison. Additionally, postpartum blood glucose will be measured 4 hours after childbirth. Participants will be approached during routine prenatal visits and will complete informed consent during standard care appointments. The study aims to collect data through April 2028.

CONDITIONS

Brief Title

Validating CGM for GDM

Research Team

N

Nicola F Tavella, MPH

V

Victoria Ly, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here